Merit Medical Ownership
| MMSI Stock | USD 103.66 0.34 0.33% |
Shares in Circulation | First Issued 1989-03-31 | Previous Quarter 58.7 M | Current Value 59.5 M | Avarage Shares Outstanding 36.2 M | Quarterly Volatility 13.3 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Merit |
Merit Stock Ownership Analysis
About 98.0% of the company shares are owned by institutional investors. The book value of Merit Medical was now reported as 22.71. The company has Price/Earnings To Growth (PEG) ratio of 2.39. Merit Medical Systems had not issued any dividends in recent years. The entity had 5:4 split on the 6th of May 2011. Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah. Merit Medical operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 6446 people. To find out more about Merit Medical Systems contact Fred Lampropoulos at 801 253 1600 or learn more at https://www.merit.com.Besides selling stocks to institutional investors, Merit Medical also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Merit Medical's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Merit Medical's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Merit Medical Quarterly Liabilities And Stockholders Equity |
|
Merit Medical Insider Trades History
Roughly 2.0% of Merit Medical Systems are currently held by insiders. Unlike Merit Medical's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Merit Medical's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Merit Medical's insider trades
Merit Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Merit Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Merit Medical Systems backward and forwards among themselves. Merit Medical's institutional investor refers to the entity that pools money to purchase Merit Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Dimensional Fund Advisors, Inc. | 2024-09-30 | 1.2 M | Amvescap Plc. | 2024-06-30 | 1.2 M | Loomis, Sayles & Company Lp | 2024-06-30 | 1.1 M | Royal Bank Of Canada | 2024-06-30 | 947.6 K | Greenhouse Funds Lllp | 2024-06-30 | 925.9 K | Aristotle Capital Boston, Llc | 2024-06-30 | 794.6 K | Norges Bank | 2024-06-30 | 782.7 K | T. Rowe Price Associates, Inc. | 2024-06-30 | 780.5 K | Charles Schwab Investment Management Inc | 2024-09-30 | 727.3 K | Blackrock Inc | 2024-06-30 | 8.9 M | Vanguard Group Inc | 2024-09-30 | 6.6 M |
Merit Medical Systems Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Merit Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Merit Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Merit Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Merit Medical Outstanding Bonds
Merit Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Merit Medical Systems uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Merit bonds can be classified according to their maturity, which is the date when Merit Medical Systems has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| MET 37 13 JUN 25 Corp BondUS58989V2E38 | View | |
| MET 125 14 SEP 26 Corp BondUS58989V2D54 | View |
Merit Medical Corporate Filings
F4 | 18th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
8K | 1st of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 29th of August 2024 Other Reports | ViewVerify |
Currently Active Assets on Macroaxis
When determining whether Merit Medical Systems offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Merit Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Merit Medical Systems Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Merit Medical Systems Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merit Medical Systems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merit Medical. If investors know Merit will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Merit Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.091 | Earnings Share 2.05 | Revenue Per Share 22.847 | Quarterly Revenue Growth 0.078 | Return On Assets 0.0456 |
The market value of Merit Medical Systems is measured differently than its book value, which is the value of Merit that is recorded on the company's balance sheet. Investors also form their own opinion of Merit Medical's value that differs from its market value or its book value, called intrinsic value, which is Merit Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merit Medical's market value can be influenced by many factors that don't directly affect Merit Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Merit Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Merit Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merit Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.